Literature DB >> 17206687

Occult hepatitis B and infliximab-induced HBV reactivation.

Salvatore Madonia, Ambrogio Orlando, Daniela Scimeca, Mirko Olivo, Francesca Rossi, Mario Cottone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17206687     DOI： 10.1002/ibd.20035

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  26 in total

1.  Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy.

Authors:  Arie Regev
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

2.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

3.  Medical management of Crohn's disease.

Authors:  Paul A Feldman; Daniel Wolfson; Jamie S Barkin
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 4.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

Review 5.  Infliximab-related hepatitis: a case study and literature review.

Authors:  Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal:  Dig Dis Sci       Date:  2013-05-05       Impact factor: 3.199

Review 6.  What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

Authors:  Gianluca Andrisani; Alessandro Armuzzi; Manuela Marzo; Carla Felice; Daniela Pugliese; Alfredo Papa; Luisa Guidi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 7.  Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors:  Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 8.  Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Authors:  Masaru Kato; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2015-11-16       Impact factor: 2.631

9.  Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.

Authors:  Keisuke Ojiro; Makoto Naganuma; Hirotoshi Ebinuma; Hiroyoshi Kunimoto; Shinichiro Tada; Haruhiko Ogata; Yasushi Iwao; Hidetsugu Saito; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 10.  Persistent occult hepatitis B virus infection: experimental findings and clinical implications.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.